Galectin-8 Contributes to Human Trophoblast Cell Invasion.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
20 Sep 2024
Historique:
received: 01 08 2024
revised: 13 09 2024
accepted: 16 09 2024
medline: 29 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Galectins are a class of lectins that are extensively expressed in all organisms. Galectins are involved in a range of functions, including early development, tissue regeneration, cancer and inflammation. It has been shown that galectin-8 is expressed in the villous and extravillous trophoblast (EVT) cells of the human placenta; however, its physiological role in pregnancy establishment has not been elucidated. Taking these factors into account, we investigated the functional role of galectin-8 in HTR-8/SVneo cells-a human EVT cell line-and human primary cytotrophoblast cells isolated from a first-trimester placenta. We analyzed the effects of recombinant human galectin-8 (rh galectin-8) on the adhesion, migration and invasion of HTR-8/SVneo cells. We used qPCR, cell-based ELISA (cELISA) and gelatin zymography to study the effects of galectin-8 on mediators of these processes, such as integrin subunits alpha-1 and beta-1 and matrix metalloproteinases (MMPs)-2 and -9, on the mRNA and protein levels. Further, we studied the effects of galectin-8 on primary cytotrophoblast cells' invasion. Galectin-8 stimulated the adhesion, migration and invasion of HTR-8/SVneo cells, as well as the invasion of primary cytotrophoblasts. In addition, the MMP-2 and -9 levels were increased, while the expression of integrins alpha-1 and beta-1 was not affected. Galectin-8 has the ability to positively affect EVTs' invasion, so it can be considered a significant factor in the trophoblast cell invasion process.

Identifiants

pubmed: 39337581
pii: ijms251810096
doi: 10.3390/ijms251810096
pii:
doi:

Substances chimiques

Galectins 0
LGALS8 protein, human 0
Matrix Metalloproteinase 2 EC 3.4.24.24
Matrix Metalloproteinase 9 EC 3.4.24.35
Recombinant Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Institute for the application of nuclear energy, University of Belgrade, Serbia
ID : n/a

Auteurs

Janko Legner (J)

Department for Biology of Reproduction, Institute for the Application of Nuclear Energy, University of Belgrade, 11000 Belgrade, Serbia.

Milica Jovanović Krivokuća (M)

Department for Biology of Reproduction, Institute for the Application of Nuclear Energy, University of Belgrade, 11000 Belgrade, Serbia.

Aleksandra Vilotić (A)

Department for Biology of Reproduction, Institute for the Application of Nuclear Energy, University of Belgrade, 11000 Belgrade, Serbia.

Andrea Pirković (A)

Department for Biology of Reproduction, Institute for the Application of Nuclear Energy, University of Belgrade, 11000 Belgrade, Serbia.

Mirjana Nacka-Aleksić (M)

Department for Biology of Reproduction, Institute for the Application of Nuclear Energy, University of Belgrade, 11000 Belgrade, Serbia.

Žanka Bojić-Trbojević (Ž)

Department for Biology of Reproduction, Institute for the Application of Nuclear Energy, University of Belgrade, 11000 Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH